These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6091395)

  • 21. Assessment of neurotoxicity of clioquinol (Enterovioform) by visual evoked potentials. A preliminary communication.
    Bhasin DK; Raina R; Mehta SK; Arora MM
    Indian J Gastroenterol; 1985 Jul; 4(3):165-6. PubMed ID: 3160659
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical analysis of longstanding subacute myelo-optico-neuropathy: sequelae of clioquinol at 32 years after its ban.
    Konagaya M; Matsumoto A; Takase S; Mizutani T; Sobue G; Konishi T; Hayabara T; Iwashita H; Ujihira T; Miyata K; Matsuoka Y
    J Neurol Sci; 2004 Mar; 218(1-2):85-90. PubMed ID: 14759638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subacute myelo-optico-neuropathy (SMON) in Japan. With special reference to the autopsy cases.
    Egashira Y; Matsuyama H
    Acta Pathol Jpn; 1982; 32 Suppl 1():101-16. PubMed ID: 6316716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clioquinol neurotoxicity among multiple sclerosis patients?
    Herxheimer A; Bursill M
    J R Coll Gen Pract; 1983 Aug; 33(253):535-6. PubMed ID: 6224932
    [No Abstract]   [Full Text] [Related]  

  • 25. Neurotoxicity of halogenated hydroxyquinolines.
    Baumgartner G; Gilland O; Kaeser HE; Pallis CA; Rose FC; Schaumburg HH; Thomas PK; Wadia NH
    J Neurol Neurosurg Psychiatry; 1984 Jan; 47(1):100. PubMed ID: 6229608
    [No Abstract]   [Full Text] [Related]  

  • 26. Diminished skin vasodilator response to local heating in patients with long-standingsubacute myelo-optico-neuropathy.
    Yamanaka Y; Asahina M; Akaogi Y; Koyama Y; Hattori T
    J Neurol Sci; 2007 Sep; 260(1-2):214-8. PubMed ID: 17572442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zinc deficiency, acrodermatitis enteropathica, optic atrophy, subacute myelo-optic neuropathy, and 5,7-dihalo-8-quinolinols.
    Sturtevant FM
    Pediatrics; 1980 Mar; 65(3):610-3. PubMed ID: 6444713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subacute myelo-optico-neuropathy: clioquinol intoxication in humans and animals.
    Tateishi J
    Neuropathology; 2000 Sep; 20 Suppl():S20-4. PubMed ID: 11037182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bilateral optic atrophy in a one and one-half-year-old child possibly a result of administration of iodochlorhydroxyquinoline (Enterovioform)].
    Drukker J; Lindenburg PA
    Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1618-20. PubMed ID: 4262826
    [No Abstract]   [Full Text] [Related]  

  • 30. Visual failure in a patient with ulcerative colitis treated by clioquinol.
    Billson FH; Reich J; Hopkins IJ
    Lancet; 1972 May; 1(7758):1015-6. PubMed ID: 4112337
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clioquinol].
    Jurkiewicz A; Zeitune JM; Nobre MR; Endo RM; Sanvito WL
    Rev Paul Med; 1985; 103(6):297-300. PubMed ID: 2945249
    [No Abstract]   [Full Text] [Related]  

  • 32. Myelopathy following clioquinol.
    Korczyn AD; Kuritzky A; Bechar M
    Harefuah; 1977 May; 92(10):456-8. PubMed ID: 142039
    [No Abstract]   [Full Text] [Related]  

  • 33. Clioquinol and neurological disease.
    Br Med J; 1971 May; 2(5757):291-2. PubMed ID: 4252528
    [No Abstract]   [Full Text] [Related]  

  • 34. [Persistence of the neurologic risk of clioquinol].
    Devoize JL; Calmette I; Lavarenne J; Tournilhac M
    Presse Med; 1983 Nov; 12(40):2532. PubMed ID: 6227908
    [No Abstract]   [Full Text] [Related]  

  • 35. Clioquinol intoxication occurring in the treatment of acrodermatitis enteropathica with reference to SMON outside of Japan.
    Hanakago R; Uono M
    Clin Toxicol; 1981 Dec; 18(12):1427-34. PubMed ID: 6460590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxic damage to the optic nerve caused by iodochlorhydroxyquinoline (enterovioform).
    van Balen AT
    Ophthalmologica; 1971; 163(1):8-9. PubMed ID: 4257124
    [No Abstract]   [Full Text] [Related]  

  • 37. [The prevalence of dementia in subacute myelo-optico-neuropathy (SMON) patients who underwent medical checkups].
    Saito Y; Sakai K; Konagaya M
    Nihon Ronen Igakkai Zasshi; 2016; 53(2):152-7. PubMed ID: 27250222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clioquinol and related drugs.
    Br Med J; 1979 Sep; 2(6190):607. PubMed ID: 159088
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prospective study on the side-effects of the clioquinol preparation mexaform with special reference to subacute myelo-optic neuropathy].
    Bezjak B; Breintenfeld V; Schönwald S; Car V; Puskarić-Hamel N; Vrancić J; Hotujac L
    Lijec Vjesn; 1974 Sep; 96(9):553-6. PubMed ID: 4281043
    [No Abstract]   [Full Text] [Related]  

  • 40. [Toward the complete understanding of the pathogenic mechanism of clioquinol-induced subacute myelo-optic neuropathy (SMON)].
    Katsuyama M
    Nihon Yakurigaku Zasshi; 2024; 159(2):78-82. PubMed ID: 38432923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.